Identify Patients Who May Qualify for Meds to Prevent COVID-19 After Exposure

September 2021

You'll hear buzz about Regen-COV (casirivimab/imdevimab), the first med to PREVENT COVID-19...especially with cases on the rise.

This monoclonal antibody combo blocks the virus that causes COVID-19...SARS-CoV-2...from entering cells.

It's given as an IV infusion...or as 4 subcutaneous injections.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote